Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorAyhan, Sevgi
dc.contributor.authorHançerlioğulları, Necati
dc.contributor.authorGüney, Gürhan
dc.contributor.authorGözükücük, Murat
dc.contributor.authorÇaydere, Muzaffer
dc.contributor.authorGüney, Sergül Selvi
dc.contributor.authorTokmak, Aytekin
dc.contributor.authorÜstün, Yusuf
dc.date.accessioned2024-08-07T07:55:21Z
dc.date.available2024-08-07T07:55:21Z
dc.date.issued2023en_US
dc.identifier.issn1757-2215
dc.identifier.urihttps://doi.org/10.1186/s13048-023-01259-2
dc.identifier.urihttps://hdl.handle.net/20.500.12462/14953
dc.descriptionGüney, Gürhan (Balikesir Author)en_US
dc.description.abstractBackground: We aimed to determine whether adding metformin to carboplatin treatment would reduce the damage to ovarian reserve associated with carboplatin use. Methods: We included 35 adult female non-pregnant albino Wistar rats approximately three months old, weighing 220–310 g. The rats were divided into five groups of seven rats according to the treatment they received. Carboplatin and salin was given to Group 2, and carboplatin plus metformin was given to Group 3. Group 4 was administered only metformin. Group 5 was administered only salin. Carboplatin was given to Groups 2 and 3 as a single dose on the 15th day, while metformin was given to Groups 3 and 4 during the 28-day experiment. After oophorectomy, histopathologic analyses of primordial, primary, secondary, and tertiary Graff follicles according to the epithelial cells surrounding the oocyte and total follicular number were conducted per section. Serum Anti-Mullerian Hormone (AMH), tissue catalase, and malonyl dialdehyde levels were measured and compared within each group. Results: The baseline and 15th-day serum AMH values of the menstrual cycle were compared among the groups, and no statistically significant differences were observed (p > 0.05). Group 3, which was given both carboplatin and metformin, had statistically significantly higher 28th-day AMH levels than Group 2, which was given only carboplatin and saline (p < 0.001). The number of primordial follicles in Group 3 was found to be statistically significantly higher than in Group 2 (p < 0.001). Tissue catalase enzyme levels in Group 3 were statistically significantly higher than in Group 2 (p < 0.001). Tissue malondialdehyde levels in Group 2 were statistically significantly higher than tissue malondialdehyde levels in Groups 3 and 4 (p < 0.001). Conclusions: Metformin may attenuate carboplatin-induced ovarian damage, possibly through its antioxidative effects.en_US
dc.language.isoengen_US
dc.publisherBioMed Central Ltden_US
dc.relation.isversionof10.1186/s13048-023-01259-2en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subjectAMHen_US
dc.subjectAntioxidanten_US
dc.subjectCarboplatinen_US
dc.subjectCatalaseen_US
dc.subjectMalondialdehydeen_US
dc.subjectMetforminen_US
dc.subjectOvarian Canceren_US
dc.titleDoes the addition of metformin to carboplatin treatment decreases ovarian reserve damage associated with carboplatin usage?en_US
dc.typearticleen_US
dc.relation.journalJournal of Ovarian Researchen_US
dc.contributor.departmentTıp Fakültesien_US
dc.contributor.authorID0000000257447992en_US
dc.contributor.authorID0000-0002-0093-2743en_US
dc.contributor.authorID0000-0001-5739-5689en_US
dc.contributor.authorID0000-0003-1529-2555en_US
dc.identifier.volume16en_US
dc.identifier.issue1en_US
dc.identifier.startpage1en_US
dc.identifier.endpage8en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster

info:eu-repo/semantics/openAccess
Aksi belirtilmediği sürece bu öğenin lisansı: info:eu-repo/semantics/openAccess